Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lansoprazole - Takeda

Drug Profile

Lansoprazole - Takeda

Alternative Names: A-65006; AG-1749; Agopton; Bamalite; Estomil; Ilsatec; Lampion; Lansap; Lansone; Lansox; Lanzo; Lanzor; Limpidex; Ogast; Ogastro; Opiren; Prevacid; Prevacid 24HR; Prezal; Pro-Ulco; Takepron; Takepron Capsules 15; Takepron OD Tablets 15; TakepronIV; Zoton

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Takeda
  • Class Antiulcers; Benzimidazoles; Gastric antisecretories; Pyridines; Small molecules; Sulfoxides
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Zollinger-Ellison syndrome
  • No development reported Gastritis
  • Discontinued Bleeding ulcer

Most Recent Events

  • 21 Feb 2013 Registered for Gastritis (in combination with amoxicillin and clarithromycin or metronidazole as triple therapy for Helicobacter pylori gastritis) in Japan (PO)
  • 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
  • 31 Aug 2012 Preregistration for Helicobacter pylori Gastritis (in combination with amoxicillin hydrate, and either clarithromycin or metronidazole) in Japan (PO)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top